Hims & Hers Health Long Term Debt 2020-2025 | HIMS
Hims & Hers Health long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Hims & Hers Health long term debt for the quarter ending September 30, 2025 was $0.971B, a 0% increase year-over-year.
- Hims & Hers Health long term debt for 2024 was $0B, a 0% decline from 2023.
- Hims & Hers Health long term debt for 2023 was $0B, a 0% decline from 2022.
- Hims & Hers Health long term debt for 2022 was $0B, a 0% decline from 2021.
|
Hims & Hers Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
|
Hims & Hers Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $971 |
| 2025-06-30 | $969 |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.345B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $30.222B | 34.95 |
| Tempus AI (TEM) | United States | $9.329B | 0.00 |
| Doximity (DOCS) | United States | $6.273B | 26.66 |
| IRhythm Holdings (IRTC) | United States | $4.728B | 0.00 |
| Privia Health (PRVA) | United States | $2.646B | 165.46 |
| Hinge Health (HNGE) | United States | $2.502B | 0.00 |
| 10x Genomics (TXG) | United States | $2.240B | 0.00 |
| Heartflow (HTFL) | United States | $2.213B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.906B | 31.54 |
| Omnicell (OMCL) | United States | $1.754B | 48.85 |
| Azenta (AZTA) | United States | $1.281B | 51.57 |
| Enovis (ENOV) | United States | $1.246B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.054B | 0.00 |
| Schrodinger (SDGR) | United States | $0.953B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.816B | 0.00 |
| Phreesia (PHR) | United States | $0.759B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.733B | 0.00 |
| Talkspace (TALK) | United States | $0.628B | 126.33 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Claritev (CTEV) | United States | $0.425B | 0.00 |
| Evolent Health (EVH) | United States | $0.323B | 0.00 |
| TruBridge (TBRG) | United States | $0.312B | 14.36 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.311B | 0.00 |
| Carlsmed (CARL) | United States | $0.300B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.282B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.236B | 0.00 |
| CapsoVision (CV) | United States | $0.228B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.226B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.156B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.148B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 5.23 |
| Outset Medical (OM) | United States | $0.080B | 0.00 |
| American Well (AMWL) | United States | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.036B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.015B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.014B | 0.00 |
| Movano (MOVE) | United States | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.006B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.006B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |